Search Results for "Latest News On Cdsco"
For the latest news on mergers and acquisitions in the industry, try the BioPortfolio Twitter feed and Facebook pages . . . (coming soon!)
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Latest Biotherapeutics News - RSS feed - Twitter account - @Biotherapeutic1 -...
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Latest Pharmaceutical and Biotechnology Collabor...
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusi...
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease...
The Indian CDSCO wants drug companies to withdraw defective drugs faster and to practice for such recalls.
The CDSCO has started prescreening applications to register clinical trial ethics committees in a move designed to streamline the approval process.
An Indian export group has published what it claims are draft CDSCO guidelines setting out what API makers must do to comply with EU import rules that come into effect this summer.
Indian drug manufacturers have 18 months to test drugs not approved by India’s Central Drugs Standard Control Organization (CDSCO) for efficacy and safety or they will be pulled from the market.
Inspectors will be able to visit clinical trial sites unannounced and seize records under new draft guidelines issued by the Indian Central Drugs Standard Control Organisation (CDSCO).
The CDSCO wants to expand its pool of reviewers for drug applications, clinical trials and medical devices and is seeking applications from experts.
Reports citing WHO data on the number of fake drugs produced and sold in India are wrong according to the CDSCO.
Drugmakers and importers are not complying with safety reporting requirements according to the Indian Drugs Controller General (DCG), which has given the offending firms three weeks to comply.
Matching PubMed Articles
Personal reports of receiving bad news provide data that describes patients' comprehension, reflections, experienced emotions, and an interpretative commentary with the wisdom of hindsight. Analysis o...
News, Views and Reviews provides focused updates, topic reviews and editorials concerning the latest developments in dermatologic therapy.